Literature DB >> 15246051

Regulation of the trafficking of tumour-infiltrating dendritic cells by chemokines.

Alain P Vicari1, Isabelle Treilleux, Serge Lebecque.   

Abstract

To anticipate and initiate immune responses, dendritic cells follow a migratory route from their recruitment as sentinels into tissues, including solid tumors, then to secondary lymphoid organs where they profile the immune response. Migratory capacities--and especially chemokine responsiveness--are therefore key elements in dendritic cell biology. Here, we will review our current knowledge about tumour-infiltrating dendritic cells and the chemokine-driven migration flows in and out from tumors. Then we will discuss the consequences of the interactions between dendritic cells and tumors and the perspectives for translating our experimental knowledge of manipulating dendritic cell migratory flows into anti-cancer therapies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246051     DOI: 10.1016/j.semcancer.2003.10.002

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  13 in total

Review 1.  Molecular mechanisms involved in dendritic cell dysfunction in cancer.

Authors:  Michael Tang; Jun Diao; Mark S Cattral
Journal:  Cell Mol Life Sci       Date:  2016-08-05       Impact factor: 9.261

2.  T cell density and location can influence the prognosis of ovarian cancer.

Authors:  Ahmad Al-Attar; Mohamed Shehata; Lindy Durrant; Paul Moseley; Suha Deen; Stephen Chan
Journal:  Pathol Oncol Res       Date:  2009-12-19       Impact factor: 3.201

Review 3.  Chemokines in health and disease.

Authors:  Dayanidhi Raman; Tammy Sobolik-Delmaire; Ann Richmond
Journal:  Exp Cell Res       Date:  2011-01-09       Impact factor: 3.905

4.  Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.

Authors:  Sofie Struyf; Laura Salogni; Marie D Burdick; Jo Vandercappellen; Mieke Gouwy; Sam Noppen; Paul Proost; Ghislain Opdenakker; Marc Parmentier; Craig Gerard; Silvano Sozzani; Robert M Strieter; Jo Van Damme
Journal:  Blood       Date:  2010-10-27       Impact factor: 22.113

Review 5.  The role of CXC chemokines and their receptors in the progression and treatment of tumors.

Authors:  Qingchao Zhu; Xiaodong Han; Jiayuan Peng; Huanlong Qin; Yu Wang
Journal:  J Mol Histol       Date:  2012-06-30       Impact factor: 2.611

Review 6.  Organ selectivity in metastasis: regulation by chemokines and their receptors.

Authors:  Adit Ben-Baruch
Journal:  Clin Exp Metastasis       Date:  2007-09-21       Impact factor: 5.150

Review 7.  Role of chemokines in tumor growth.

Authors:  Dayanidhi Raman; Paige J Baugher; Yee Mon Thu; Ann Richmond
Journal:  Cancer Lett       Date:  2007-07-12       Impact factor: 8.679

8.  Melanoma-infiltrating dendritic cells: Limitations and opportunities of mouse models.

Authors:  Jared S Klarquist; Edith M Janssen
Journal:  Oncoimmunology       Date:  2012-12-01       Impact factor: 8.110

9.  Role of IL-12p40 in cervical carcinoma.

Authors:  H J M A A Zijlmans; S Punt; G J Fleuren; J B Trimbos; G G Kenter; A Gorter
Journal:  Br J Cancer       Date:  2012-10-25       Impact factor: 7.640

10.  T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1.

Authors:  Malika Trad; Alexandrine Gautheron; Jennifer Fraszczak; Darya Alizadeh; Claire Larmonier; Collin J LaCasse; Sara Centuori; Sylvain Audia; Maxime Samson; Marion Ciudad; Francis Bonnefoy; Stéphanie Lemaire-Ewing; Emmanuel Katsanis; Sylvain Perruche; Philippe Saas; Bernard Bonnotte
Journal:  Biomed Res Int       Date:  2015-09-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.